This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Peter Jules Van Daele: Innovator in Pharmaceutical Science
Introduction
Peter Jules Van Daele is a notable inventor based in Grimbergen, Belgium. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on benzamide derivatives. His research focuses on developing solutions for medical conditions that involve decreased intestinal motility.
Latest Patents
Peter Jules Van Daele holds a patent for a novel benzamide derivative, which is described in his patent titled "Enterokinetic benzamide." This invention involves pharmaceutical compositions that comprise these novel compounds, processes for preparing them, and their use as medicine. The primary application of this invention is in treating conditions related to decreased motility of the intestine. He has 1 patent to his name.
Career Highlights
Peter is associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to contribute to the development of innovative medical solutions. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Peter has collaborated with notable individuals, including Georges H Van Daele, who is deceased, and Marie-Louise Hendrickx, who is also an heir. These collaborations have enriched his research and contributed to the advancement of pharmaceutical sciences.
Conclusion
Peter Jules Van Daele is a distinguished inventor whose work in pharmaceutical innovation has the potential to impact medical treatments significantly. His contributions, particularly in the area of benzamide derivatives, highlight the importance of research in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
